Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Depression present in late life and midlife significantly increased the risk for all-cause dementia based on pooled hazard ratios (hazard ratios, 1.95 and 1.56, respectively). HealthDay News — ...

There was no significant sex differences in toddlers with autism spectrum disorder across 17 of 18 measures, including symptom severity, receptive and expressive language, and social attention.

A quality improvement strategy can improve electronic health record-based screening for depression and anxiety in people with epilepsy.

Patients with acute episodic migraine consistently prioritize pain relief over other treatment attributes such as route of administration, adverse outcomes, and costs, according to study results ...

HealthDay News — Military service does not appear to increase the risk of depression, according to a study published online May 29 in BMJ Military Health.

Patients with Alzheimer disease and cognitive impairment with delayed REM sleep patterns have increased levels of brain amyloid and tau.

Central hypersomnolence disorders, such as narcolepsy type 2 and idiopathic hypersomnia, are associated with reduced health-related quality of life.

The Food and Drug Administration has granted Fast Track designation to ATH434 for the treatment of multiple system atrophy.

Shifting patterns in ischemic stroke mortality and death locations across US populations highlight disparities and end-of-life care needs.

Maternal self-efficacy demonstrated a significant moderating effect on the association between infant sleep and maternal well-being.

Allergic diseases, including asthma, atopic dermatitis, and allergic rhinitis, are associated with a significantly higher risk for migraines.